David A. Siegel Royalty Pharma PLC Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Two Sigma Advisers, LP holds 3,033,200 shares of RPRX stock, worth $78.4 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
3,033,200
Previous 2,096,300
44.69%
Holding current value
$78.4 Million
Previous $55.3 Million
55.23%
% of portfolio
0.21%
Previous 0.13%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
283MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.06 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$971 Million0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$595 Million0.01% of portfolio
-
Baillie Gifford & CO16.1MShares$417 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$313 Million1.32% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...